FDA Embraces AI: Rapid Agency-Wide Rollout After Successful Pilot
In a groundbreaking move, the FDA has announced an aggressive timeline to integrate AI across all centers by June 30, 2025, following a successful pilot that significantly reduced scientific review times from days to minutes, promising to accelerate the approval process for new therapies.